{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:30:57Z","timestamp":1777681857090,"version":"3.51.4"},"reference-count":20,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Hosp Pharm"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:p>Dasatinib, a Tyrosine kinase inhibitor, functions by preventing an abnormal protein that instructs cancer cells to proliferate. It is used to treat chronic myeloid leukemia in adults who can no longer benefit from other leukemia medications, including imatinib, or those who cannot tolerate first-line medicines due to their side effects. Pleural effusion and pulmonary hypertension induced by the drug dasatinib are uncommon but serious complications that impact the pulmonary vasculature. Here, we describe a series of patients with chronic myeloid leukemia receiving dasatinib who subsequently experienced pleural effusion and pulmonary hypertension. In 2 of the 3 cases, dasatinib was used as first-line therapy, highlighting the importance of recognizing these adverse effects even when it is used upfront rather than solely after failure of first-generation TKIs. The patient\u2019s symptoms significantly improved after stopping dasatinib and starting supportive care. This case series emphasizes the need to raise awareness among clinicians, the importance of early recognition, and the timely initiation of alternative treatment to enhance patient outcomes.<\/jats:p>","DOI":"10.1177\/00185787251348384","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T12:03:07Z","timestamp":1752753787000},"page":"23-29","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Dasatinib Induced Pulmonary Hypertension and Third Space Effusion: A Case Series and Literature Review"],"prefix":"10.1177","volume":"61","author":[{"given":"Kiran","family":"Pura Krishnamurthy","sequence":"first","affiliation":[{"name":"JSS Medical College, Mysuru, Karnataka, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8710-2397","authenticated-orcid":false,"given":"Manjappa","family":"Mahadevappa","sequence":"additional","affiliation":[{"name":"JSS Medical College, Mysuru, Karnataka, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7792-8576","authenticated-orcid":false,"given":"Bharath Raj","family":"Srinivasan","sequence":"additional","affiliation":[{"name":"JSS College of Pharmacy, Mysuru, Karnataka, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4708-9868","authenticated-orcid":false,"given":"Himabindu","family":"Jayaprakash Narayan","sequence":"additional","affiliation":[{"name":"JSS College of Pharmacy, Mysuru, Karnataka, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,7,17]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.079921"},{"key":"e_1_3_2_3_2","unstructured":"Flynn JP Gerriets V. Imatinib. xPharm: The Comprehensive Pharmacology Reference [Internet]. June 20 2023. Accessed May 14 2025 1-7. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK551676\/"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1177\/1078155217753740"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","unstructured":"Montani D Seferian A Savale L Simonneau G Humbert M. Drug-induced pulmonary arterial hypertension: a recent outbreak. Eur Respir Rev. 2013;22(129):244-250. https:\/\/pubmed.ncbi.nlm.nih.gov\/23997051\/","DOI":"10.1183\/09059180.00003313"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01913-2018"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/EURHEARTJ\/EHV317"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.21693\/1933-088X-17.2.69"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2466-11-30"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1186\/S13256-017-1515-9"},{"key":"e_1_3_2_11_2","unstructured":"Dasatinib: Adverse Effects. In: Micromedex (electronic version). Merative US L.P. 2025. Accessed January 21 2025. https:\/\/www.micromedexsolutions.com\/micromedex2\/librarian\/PFDefaultActionId\/evidencexpert.DoIntegratedSearch?navitem=topHome&isToolPage=true#"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1177\/2045893217733444"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.2147\/RRCC.S316980"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3895197"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1177\/2045894019865704"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.12.0329"},{"key":"e_1_3_2_17_2","volume-title":"The use of the WHO-UMC system for standardised case causality assessment","author":"UMC","unstructured":"UMC. The use of the WHO-UMC system for standardised case causality assessment. The Uppsala Monitoring Centre. Published online 2018."},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154"},{"issue":"6","key":"e_1_3_2_19_2","first-page":"538","article-title":"Focusing on the preventability of adverse drug reactions","volume":"27","author":"Schumock GT","year":"1992","unstructured":"Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm. 1992;27(6):538.","journal-title":"Hosp Pharm"},{"issue":"3","key":"e_1_3_2_20_2","first-page":"1293","article-title":"Preventability, predictability and seriousness of adverse drug reactions amongst medicine inpatients in a teaching hospital: a prospective observational study","volume":"1","author":"Raut AL","year":"2012","unstructured":"Raut AL, Patel P, Patel C, Pawar A. Preventability, predictability and seriousness of adverse drug reactions amongst medicine inpatients in a teaching hospital: a prospective observational study. Int J Pharm Chem Sci. 2012;1(3):1293-1299.","journal-title":"Int J Pharm Chem Sci"},{"issue":"1","key":"e_1_3_2_21_2","first-page":"1012","article-title":"Identification of risk factors for medication errors in hospital geriatric departments","volume":"2","author":"Bai M","year":"2021","unstructured":"Bai M, Pratap U, Sandhya L, et al. Identification of risk factors for medication errors in hospital geriatric departments. J Clin Pharmacol Ther. 2021;2(1):1012.","journal-title":"J Clin Pharmacol Ther"}],"container-title":["Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00185787251348384","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/00185787251348384","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00185787251348384","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:41:13Z","timestamp":1777452073000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/00185787251348384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,17]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1177\/00185787251348384"],"URL":"https:\/\/doi.org\/10.1177\/00185787251348384","relation":{},"ISSN":["0018-5787","1945-1253"],"issn-type":[{"value":"0018-5787","type":"print"},{"value":"1945-1253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,17]]}}}